J. Mimuro

J. Mimuro, D. Loskutoff, D. Seiffert, 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

Unbalanced expression of ADAMTS13 and von Willebrand factor in mouse endotoxinemia.

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2008, Thrombosis research.

cDNA for bovine type 1 plasminogen activator inhibitor (PAI-1).

J. Mimuro, M. Sawdey, M. Hattori, 1989, Nucleic acids research.

Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.

J. Mimuro, Y. Sakata, I. Kitajima, 2014, Thrombosis research.

[Plasminogen activator inhibitor 1 (PAI-1)].

J. Mimuro, 1999, Nihon rinsho. Japanese journal of clinical medicine.

Effect of staphylokinase concentration of plasminogen activation.

S. Madoiwa, J. Mimuro, Y. Sakata, 1995, Biochimica et biophysica acta.

Intra‐articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII‐deficient mice

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2012, Journal of thrombosis and haemostasis : JTH.

Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study

T. Ohmori, S. Madoiwa, J. Mimuro, 2014, Critical Care.

Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin.

J. Mimuro, N. Aoki, A. Ichinose, 1984, Thrombosis research.

Liver‐restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII‐deficient mice

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2009, The journal of gene medicine.

Efficient expression of a transgene in platelets using simian immunodeficiency virus‐based vector harboring glycoprotein Ibα promoter: in vivo model for platelet‐targeting gene therapy

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Acquired Hemophilia A with a Rare Presentation of Acute Subdural Hematoma

J. Mimuro, Y. Hayashi, Y. Sehara, 2015, Case reports in neurological medicine.

Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency

K. Tabei, H. Nakasone, R. Yamazaki, 2013, Hematology.

Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors.

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2013, Thrombosis research.

Phenotypic correction of hemophilia A by ectopic expression of activated factor VII in platelets.

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Living donor liver transplantation from an asymptomatic donor with mild coagulation factor IX deficiency: Report of a case

S. Madoiwa, J. Mimuro, A. Miki, 2014, Pediatric transplantation.

Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene.

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2006, Thrombosis research.

Immune response against serial infusion of factor VIII antigen through an implantable venous‐access device system in haemophilia A mice

T. Ohmori, Y. Kashiwakura, S. Madoiwa, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Integration-free and stable expression of FVIII using a human artificial chromosome

M. Oshimura, J. Mimuro, Y. Kazuki, 2011, Journal of Human Genetics.

Effect of glycosidase inhibitors on the biosynthesis of alpha 2-plasmin inhibitor and antithrombin III in Hep G2 cells.

J. Mimuro, Y. Sakata, M. Matsuda, 1994, Biochimica et biophysica acta.

Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bβ Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bβ Asn-158

J. Mimuro, D. Meh, M. Mosesson, 1999 .

[Type 1 plasminogen activator inhibitor].

J. Mimuro, 1990, Rinsho byori. The Japanese journal of clinical pathology.

Antagonism of Sphingosine 1-Phosphate Receptor-2 Enhances Migration of Neural Progenitor Cells Toward an Area of Brain Infarction

T. Ohmori, Y. Kashiwakura, S. Madoiwa, 2008, Stroke.

Silencing of a Targeted Protein in In Vivo Platelets Using a Lentiviral Vector Delivering Short Hairpin RNA Sequence

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Essential Roles of Sphingosine 1‐Phosphate/S1P1 Receptor Axis in the Migration of Neural Stem Cells Toward a Site of Spinal Cord Injury

T. Ohmori, S. Madoiwa, J. Mimuro, 2007, Stem cells.

Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2006, Blood.

Fibrinolytic components in fetal membranes and amniotic fluid.

J. Mimuro, Y. Sakata, T. Tamada, 1993, American journal of obstetrics and gynecology.

A classification of the fibrin network structures formed from the hereditary dysfibrinogens

H. Endo, T. Ohmori, S. Madoiwa, 2006, Journal of thrombosis and haemostasis : JTH.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysﬁbrinogen With a B b Asn-160 to Ser Substitution Associated With Extra Glycosylation at B b Asn-158

J. Mimuro, D. Meh, M. Mosesson, 1999 .

Fibrinogens Hamasaka and Tokyo III

J. Mimuro, Y. Sakata, M. Matsuda, 1991 .

PLASMINOGEN ACTIVATOR INHIBITOR

J. Mimuro, D. Loskutoff, C. Hekman, 1987, Thrombosis and Haemostasis.

[Plasminogen activator inhibitor-1 (PAI-1)].

J. Mimuro, 1999, Nihon rinsho. Japanese journal of clinical medicine.

Clot lysis induced by a monoclonal antibody against alpha 2-plasmin inhibitor.

J. Mimuro, Y. Sakata, M. Matsuda, 1989, Blood.

Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.

J. Mimuro, Y. Sakata, I. Kitajima, 2014, Thrombosis research.

Utility of intraperitoneal administration as a route of AAV serotype 5 vector‐mediated neonatal gene transfer

H. Yoshikawa, S. Madoiwa, J. Mimuro, 2006, The journal of gene medicine.

Specific detection of human coagulation factor IX in cynomolgus macaques

S. Madoiwa, J. Mimuro, Y. Sakata, 2004, Journal of thrombosis and haemostasis : JTH.

Expression of Plasminogen Activator Inhibitor 2 in the Adult and Embryonic Mouse Tissues

J. Mimuro, Y. Sakata, M. Kaneko, 1996, Thrombosis and Haemostasis.

SOLITARY VENOUS DILATATION OF THE ESOPHAGUS AND RESEMBLING SMALL ELEVATED LESIONS

J. Mimuro, F. Ikegami, Y. Sakurai, 1981 .

Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation.

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2011, Thrombosis research.

functionally active type 1 plasminogen activator inhibitor Extracellular matrix of cultured bovine aortic endothelial cells contains

J. Mimuro, D. Loskutoff, R. Schleef, 2010 .

Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis.

T. Ohmori, S. Madoiwa, J. Mimuro, 2013, Journal of critical care.

Plasminogen Activator Inhibitor 1 Promotes a Poor Prognosis in Sepsis-Induced Disseminated Intravascular Coagulation

T. Ohmori, S. Madoiwa, J. Mimuro, 2006, International journal of hematology.

The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator

J. Mimuro, T. Podor, D. Loskutoff, 1990, The Journal of cell biology.

Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation

R. Tsujita, J. Mimuro, Y. Sakata, 2014, Journal of Intensive Care.

[Type 1 plasminogen activator inhibitor: its role in biological reactions].

J. Mimuro, 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.

J. Mimuro, Y. Sakata, I. Kitajima, 2013, Thrombosis research.

Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin α) in Pediatric Patients With Disseminated Intravascular Coagulation

J. Mimuro, Y. Sakata, A. Shirahata, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Pediatric Patients With Disseminated Intravascular Coagulation ) in α Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin ( Thrombomodulin

J. Mimuro, Y. Sakata, A. Shirahata, 2014 .

Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation

J. Mimuro, Y. Sakata, A. Shirahata, 2014, European Journal of Pediatrics.

Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.

C. Tei, M. Miyata, T. Ohmori, 2008, Thrombosis research.

Hypofibrinogenemia caused by a nonsense mutation in the fibrinogen Bβ chain gene

J. Mimuro, Y. Sakata, M. Matsuda, 2003, Journal of thrombosis and haemostasis : JTH.

Monocytes modulate the fibrinolytic balance of endothelial cells.

U. Ikeda, K. Shimada, J. Mimuro, 1997, Thrombosis research.

Reversible interactions between plasminogen activators and plasminogen activator inhibitor-1.

J. Mimuro, Y. Sakata, M. Matsuda, 1992, Biochimica et biophysica acta.